Ginsenoside Rh2 as a novel PIN1 inhibitor disrupting the cancer stem cell-like phenotype in non-small cell lung cancer. [PDF]
J Transl MedLiu X +8 more
europepmc +1 more source
Ginsenoside Rh2 repressed the progression of prostate cancer through the mitochondrial damage induced by mitophagy and ferroptosis. [PDF]
Front OncolHe Z +5 more
europepmc +1 more source
Development of Certain Protein Kinase Inhibitors with the Components from Traditional Chinese Medicine [PDF]
, 2017 Ge Zhao +5 more
core +1 more source
Ginsenoside Rh2 Mitigates Endoplasmic Reticulum Stress-Induced Apoptosis and Inflammation and Through Inhibition of Hepatocyte-Macrophage Inflammatory Crosstalk. [PDF]
NutrientsPark S, Jeong I, Kim OK.
europepmc +1 more source
Ginsenoside Rh2 Suppresses Metastasis and Growth of Colon Cancer via miR-491. [PDF]
J Oncol, 2021 Wei W +6 more
europepmc +1 more source
Ginsenoside Rh2 targets SIRT1-mediated deacetylation to modulate ERĪ±/AR balance and overcome endocrine therapy resistance in prostate cancer using 3D organoid models. [PDF]
Cell Biol ToxicolChen X +7 more
europepmc +1 more source
Ginsenoside Rh2-Pretreated Mesenchymal Stem Cell Exosomes Ameliorate Collagen-Induced Arthritis via N6-Methyladenosine Methylation. [PDF]
Biomater ResZhou Z, Wu S, Li Y, Shao P, Jiang J.
europepmc +1 more source
Inhibition of macrophage polarization and pyroptosis in collagen-induced arthritis through MSC-exo and ginsenoside Rh2. [PDF]
Arthritis Res TherZhou Z, Wu S, Li Y, Shao P, Jiang J.
europepmc +1 more source
Ginsenoside Rh2 mitigates doxorubicin-induced cardiotoxicity by inhibiting apoptotic and inflammatory damage and weakening pathological remodelling in breast cancer-bearing mice. [PDF]
Cell Prolif, 2022 Hou J, Yun Y, Cui C, Kim S.
europepmc +1 more source